Anirvan Ghosh is CEO at Unity Biotechnology, Inc. (UBX). They have made 1 open-market trade across 1 company since 2022, most recently 2025-04-02.
CIK 0001807437
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UBX | 153,454 | $31K |
Shares reported on the most recent Form 4, priced at the 2025-04-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UBX | SELL | 2025-04-02 | 2025-04-03 | $1.03 | $199K | -3.0% | +7.0% | -70.2% |
| UBX | SELL · 10b5-1 | 2025-02-04 | 2025-02-05 | $2.23 | $1K | -12.6% | -27.3% | -60.2% |
| UBX | SELL · 10b5-1 | 2024-11-04 | 2024-11-06 | $1.29 | $557 | +2.6% | +2.6% | +92.2% |
| UBX | SELL · 10b5-1 | 2024-08-02 | 2024-08-06 | $1.53 | $924 | +2.2% | +9.4% | -9.4% |
| UBX | SELL · 10b5-1 | 2024-06-25 | 2024-06-26 | $1.40 | $2K | +4.4% | +7.3% | +5.1% |
| UBX | SELL · 10b5-1 | 2024-05-02 | 2024-05-03 | $1.55 | $935 | -5.6% | -1.9% | -4.9% |
| UBX | SELL · 10b5-1 | 2024-02-02 | 2024-02-05 | $1.71 | $1K | +18.5% | -1.2% | -4.8% |
| UBX | SELL · 10b5-1 | 2024-01-30 | 2024-01-31 | $1.71 | $2K | +1.7% | +1.7% | -13.0% |
| UBX | SELL · 10b5-1 | 2023-11-02 | 2023-11-03 | $1.83 | $1K | -11.2% | -6.3% | -14.6% |
| UBX | SELL · 10b5-1 | 2023-10-30 | 2023-10-31 | $1.90 | $2K | -10.0% | -4.0% | -12.5% |
| UBX | SELL · 10b5-1 | 2023-09-14 | 2023-09-15 | $2.47 | $3K | -6.9% | -29.7% | -33.6% |
| UBX | SELL · 10b5-1 | 2023-08-02 | 2023-08-03 | $2.94 | $2K | -4.7% | -6.6% | -32.5% |
| UBX | SELL · 10b5-1 | 2023-07-31 | 2023-08-01 | $2.86 | $3K | -11.6% | -9.9% | -34.7% |
| UBX | SELL · 10b5-1 | 2023-06-26 | 2023-06-27 | $3.20 | $4K | +6.2% | -6.5% | -16.1% |
| UBX | SELL · 10b5-1 | 2023-06-14 | 2023-06-15 | $3.39 | $4K | -18.6% | -6.0% | -19.9% |
| UBX | SELL · 10b5-1 | 2023-05-02 | 2023-05-03 | $2.17 | $1K | +23.7% | +37.5% | +28.0% |
| UBX | SELL · 10b5-1 | 2023-05-01 | 2023-05-02 | $2.15 | $2K | +20.7% | +43.2% | +24.8% |
| UBX | SELL · 10b5-1 | 2023-03-31 | 2023-04-03 | $1.70 | $3K | +28.1% | +51.0% | +77.8% |
| UBX | SELL · 10b5-1 | 2023-03-14 | 2023-03-15 | $4.00 | $5K | -53.1% | -52.9% | -18.3% |
| UBX | SELL · 10b5-1 | 2023-02-02 | 2023-02-03 | $4.84 | $12K | -14.3% | -7.9% | -54.9% |
| UBX | SELL · 10b5-1 | 2023-01-30 | 2023-01-31 | $4.45 | $5K | -5.0% | -1.1% | -52.4% |
| UBX | SELL · 10b5-1 | 2022-12-14 | 2022-12-15 | $2.85 | $4K | -5.1% | +48.0% | +49.8% |
| UBX | SELL · 10b5-1 | 2022-11-03 | 2022-11-04 | $2.40 | $3K | +7.1% | +21.6% | +99.2% |
| UBX | SELL · 10b5-1 | 2022-09-14 | 2022-09-15 | $0.48 | $7K | -13.4% | -11.8% | -40.3% |
| UBX | SELL · 10b5-1 | 2022-08-01 | 2022-08-02 | $0.67 | $7K | +98.5% | -31.8% | -56.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.